BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Lipitor
,
rs6983267
,
FABP1
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclin dependent kinase 6
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
Breast cancer MCF-7 cells with Abemaciclib and SR11302
Melanoma SK-MEL-5 cells treated with Palbociclib
Acute myeloid leukemia MV4-11 cells treated with BSJ-03-123, YKL-06-102 and palbociclib
Explore Curated Studies Results
Literature
Most Relevant Literature
Stabilization of CDK6 by ribosomal protein uS7, a target protein of the natural product fucoxanthino…
CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver.
CDK6 protein expression is associated with disease progression and treatment resistance in multiple …
LncRNA HAND2-AS1 attenuates glioma cell proliferation, invasion and migration by targeting CDK6.
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Pa…
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Canc…
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Pati…
Pembrolizumab + Paclitaxel in Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ